Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMPO antidepressant discontinuation trial
NL-OMON55952Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of paroxetine and venlafaxine in major depressive disorder (MDD) (2 arms), sponsored by Amsterdam University Medical Center. Started Jan 2023; status: recruiting.
02
Drugs
paroxetinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON55952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55952.